NASDAQ: PRTG - Portage Biotech Inc.

Rentabilité sur six mois: +19.08%
Rendement en dividendes: 0.00%
Secteur: Healthcare

Calendrier des promotions Portage Biotech Inc.

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise Portage Biotech Inc.

Portage Biotech Inc., together with its subsidiaries, research and develops pharmaceutical and biotechnology products.

plus de détails
The company's product pipeline includes IMM60, an iNKT cell activator that is in phase I clinical trial; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; TT-4, an adenosine receptor type 2B (A2B) inhibitor to treat solid tumors; TT-53, an A2A/A2B inhibitor to treat solid tumors; TT-10, an adenosine receptor type 2A (A2A) inhibitor to treat A2A expressing solid tumors; TT-3, an A2B inhibitor to treat colorectal and gastrointestinal cancers; and INT230-6 for the treatment of tumors. It also provides Nanolipogel co-formulation platform for delivery of DNA aptamers and certain aptamer-small molecule-based combination products; and STING agonist platform, a proprietary immune priming and boosting technology, offers various ways to target immune stimulation towards the cancer, as well as to co-deliver various signals in a single product. The company is based in Tortola, British Virgin Islands.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

IPO date 2021-02-25
ISIN VGG7185A1286
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.portagebiotech.com
Цена ао 4.54
Changement de prix par jour: -10.02% (8.88)
Changement de prix par semaine: +59.16% (5.02)
Changement de prix par mois: +88% (4.25)
Changement de prix sur 3 mois: +101.26% (3.97)
Changement de prix sur six mois: +19.08% (6.71)
Changement de prix par an: +3 512.12% (0.2212)
Evolution du prix sur 3 ans: +23.3% (6.48)
Evolution du prix sur 5 ans: +7 890% (0.1)
Evolution des prix depuis le début de l'année: +94.4% (4.11)
Tous les paramètres

Sous-estimation

Nom Signification Grade
P/S 0 0
P/BV 59.02 1
P/E 0 0
EV/EBITDA -10.52 0
Total: 2.13

Efficacité

Nom Signification Grade
ROA, % -140.94 0
ROE, % -188.19 0
Total: 0

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Devoir

Nom Signification Grade
Debt/EBITDA -0.0026 10
Total: 9.6

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % -68.4 0
Rentabilité Ebitda, % 208.46 10
Rentabilité EPS, % 459.58 10
Total: 8
Plus de détails

Établissements Volume Partager, %
Armistice Capital, LLC 1876105 10.54
Bison Wealth, LLC 213398 1.2
Peak6 Investments Llc 51221 0.29
Blackrock Inc. 35240 0.2
Renaissance Technologies, LLC 21100 0.12
Citadel Advisors Llc 14139 0.08
Beacon Investment Advisory Services, Inc. 11395 0.06
IEQ CAPITAL, LLC 11250 0.06
Dimensional Fund Advisors LP 10565 0.06
Pathstone Holdings, LLC 10100 0.06



Superviseur Titre d'emploi Paiement Année de naissance
Dr. Ian B. Walters M.B.A., M.D. CEO & Chairman of Board 967.65k 1968 (57 années)
Mr. Allan J. Lee Shaw CPA Chief Financial Officer 524.08k 1964 (61 année)
Dr. Robert A. Kramer Ph.D. Chief Scientific Officer 310.16k
Mr. Brian Wiley Chief Business Officer 220.69k 1968 (57 années)
Mr. Justin Fairchild Vice President of Development 283.83k
Mr. Joseph Ciavarella Chief Accounting Officer N/A

Adresse: British Virgin Islands, Tortola VG, Clarence Thomas Building - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.portagebiotech.com